# RAP1GAP

## Overview
RAP1GAP is a gene that encodes the RAP1 GTPase-activating protein, a crucial regulator of the small GTPase RAP1. This protein belongs to the family of GTPase-activating proteins (GAPs) and is involved in the modulation of RAP1 activity by enhancing its intrinsic GTPase activity, thereby converting RAP1 from an active GTP-bound state to an inactive GDP-bound state. RAP1GAP plays a significant role in various cellular processes, including cell adhesion, cell junction formation, and cell polarity, by regulating the balance between active and inactive states of RAP1 (Gloerich2011Regulating; Jaśkiewicz2018The). The protein's unique structure, characterized by a distinct catalytic domain and specific phosphorylation sites, allows it to interact with multiple signaling pathways, influencing cellular architecture and tissue integrity (Daumke2004Purification; Rubinfeld1992Localization). Alterations in RAP1GAP expression have been implicated in various pathological conditions, including cancer and glomerular diseases, highlighting its clinical significance (Zhang2019Function; Potla2014Podocytespecific).

## Structure
The RAP1GAP protein is characterized by a distinct molecular structure that includes a catalytic domain essential for its GTPase-activating function. This domain is located between amino acids 75 and 416, as identified through mutational analysis, and is crucial for the protein's activity in enhancing the GTP hydrolysis rate of p21rap1 (Rubinfeld1992Localization). The catalytic domain is separate from the phosphorylation sites, which are located in the carboxy-terminal region. Specific serine residues, such as Ser-484, Ser-490, and Ser-499, are identified as phosphorylation sites by cAMP-dependent kinase and p34cdc2 kinase, indicating post-translational modifications that may regulate the protein's activity (Rubinfeld1992Localization).

The structure of RAP1GAP does not share significant homology with other rasGAPs, suggesting a unique structural arrangement. Unlike other GAPs that employ a catalytic arginine, RAP1GAP utilizes two conserved lysines, Lys194 and Lys285, which are crucial for its activity (Daumke2004Purification). The protein's structure has been studied using X-ray crystallography, revealing features that contribute to its unique reaction mechanism (Daumke2004Purification).

## Function
RAP1GAP is a GTPase-activating protein that plays a critical role in regulating the activity of the small GTPase RAP1, which is involved in various cellular processes such as cell adhesion, cell junction formation, and cell polarity. RAP1GAP inactivates RAP1 by enhancing its intrinsic GTPase activity, converting RAP1 from an active GTP-bound state to an inactive GDP-bound state (Gloerich2011Regulating; Jaśkiewicz2018The). This regulation is crucial for maintaining the balance between active and inactive states of RAP1, which is important for its role in physiological processes (Jaśkiewicz2018The).

In healthy human cells, RAP1GAP is involved in the regulation of integrin-mediated cell adhesion and cell-cell junction formation, which are essential for maintaining tissue integrity and cellular architecture (Pannekoek2009Cell–cell; Caron2003Cellular). RAP1GAP is primarily active in the cytoplasm and at cell junctions, where it influences signaling pathways that affect tissue homeostasis and development (Gloerich2011Regulating). By modulating RAP1 activity, RAP1GAP plays a role in processes such as cell migration, proliferation, and the maintenance of cellular architecture, contributing to the proper functioning of various biological systems (Ding2018Methylation).

## Clinical Significance
Alterations in the expression of the RAP1GAP gene have been implicated in various cancers. In papillary thyroid carcinoma (PTC), RAP1GAP is frequently downregulated, leading to increased Rap1 activity, which is associated with enhanced cell migration and invasion, contributing to tumor progression (Zhang2019Function; Xu2020MiR31213p). The downregulation of RAP1GAP in PTC is linked to factors such as younger age, BRAF mutation, and higher recurrence risk (Xu2020MiR31213p). In squamous-cell carcinoma (SCC), RAP1GAP acts as a tumor suppressor by inactivating Rap1A and Rap1b, reducing ERK activation and proliferation (Zhang2019Function).

In medullary thyroid cancer (MTC), hyper-methylation of the RAP1GAP gene correlates with decreased expression, suggesting its potential as a diagnostic biomarker (Faam2022CpG). In cervical cancer, particularly in HPV16/18 positive cells, RAP1GAP is degraded via the ubiquitin-proteasome pathway, mediated by E6-associated protein (E6AP), which may affect cancer progression (Wang2021The).

In focal segmental glomerulosclerosis (FSGS), increased RAP1GAP expression in podocytes leads to reduced RAP1 activation, contributing to podocyte dysfunction and glomerular injury (Potla2014Podocytespecific). These findings highlight the clinical significance of RAP1GAP expression alterations in various diseases.

## Interactions
RAP1GAP interacts with several proteins, influencing various cellular processes. It binds to the activated form of Gi proteins through a GoLoco motif, which activates its GAP activity, although the exact mechanism—whether through translocation or allosteric regulation—remains unclear (Bos2007GEFs). RAP1GAP also interacts with the inactive form of Go, leading to its inactivation (Bos2007GEFs). 

RAP1GAP is targeted to the plasma membrane by binding to different Ga proteins, such as Ga i and Ga z, which reduces membrane-localized Rap1 GTP levels (Gloerich2011Regulating). It also interacts with Gαo, with a stronger affinity for the unactivated form, which sequesters RAP1GAP and facilitates Rap1 activation (Jordan1999Modulation). This interaction modulates GTPase activity and affects MAPK signaling pathways (Jordan1999Modulation).

RAP1GAP interacts with the RET receptor tyrosine kinase, a relationship enhanced by GDNF treatment. This interaction negatively regulates GDNF-induced neurite outgrowth by inhibiting ERK activation (Jiao2010Rap1GAP). These interactions highlight RAP1GAP's role in modulating signaling pathways and cellular functions.


## References


[1. (Potla2014Podocytespecific) Uma Potla, Jie Ni, Justin Vadaparampil, Guozhe Yang, Jeremy S. Leventhal, Kirk N. Campbell, Peter Y. Chuang, Alexei Morozov, John C. He, Vivette D. D’Agati, Paul E. Klotman, and Lewis Kaufman. Podocyte-specific rap1gap expression contributes to focal segmental glomerulosclerosis–associated glomerular injury. Journal of Clinical Investigation, 124(4):1757–1769, March 2014. URL: http://dx.doi.org/10.1172/jci67846, doi:10.1172/jci67846. This article has 44 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci67846)

[2. (Gloerich2011Regulating) Martijn Gloerich and Johannes L. Bos. Regulating rap small g-proteins in time and space. Trends in Cell Biology, 21(10):615–623, October 2011. URL: http://dx.doi.org/10.1016/j.tcb.2011.07.001, doi:10.1016/j.tcb.2011.07.001. This article has 132 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tcb.2011.07.001)

[3. (Wang2021The) Yinghui Wang, Yihang Xie, Boxuan Sun, Yuwei Guo, Ling Song, Dawit Eman Mohammednur, and Chunyan Zhao. The degradation of rap1gap via e6ap-mediated ubiquitin-proteasome pathway is associated with hpv16/18-infection in cervical cancer cells. Infectious Agents and Cancer, December 2021. URL: http://dx.doi.org/10.1186/s13027-021-00409-9, doi:10.1186/s13027-021-00409-9. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13027-021-00409-9)

[4. (Pannekoek2009Cell–cell) Willem-Jan Pannekoek, Matthijs R.H. Kooistra, Fried J.T. Zwartkruis, and Johannes L. Bos. Cell–cell junction formation: the role of rap1 and rap1 guanine nucleotide exchange factors. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1788(4):790–796, April 2009. URL: http://dx.doi.org/10.1016/j.bbamem.2008.12.010, doi:10.1016/j.bbamem.2008.12.010. This article has 125 citations.](https://doi.org/10.1016/j.bbamem.2008.12.010)

[5. (Daumke2004Purification) Oliver Daumke, Alfred Wittinghofer, and Michael Weyand. Purification, crystallization and preliminary structural characterization of human rap1gap. Acta Crystallographica Section D Biological Crystallography, 60(4):752–754, March 2004. URL: http://dx.doi.org/10.1107/s0907444904002392, doi:10.1107/s0907444904002392. This article has 5 citations.](https://doi.org/10.1107/s0907444904002392)

[6. (Faam2022CpG) Bita Faam, Ata. A Ghadiri, Mohammad Ali Ghaffari, Mehdi Totonchi, Atieh Amouzegar, Fereidoun Azizi, Hajiehbibi Shahbazian, Mahmoud Hashemitabar, Seyed Ahmad Fanaei, and Layasadat Khorsandi. Cpg island methylation of the rap1gap gene in medullary thyroid cancer. Archives of Iranian Medicine, 25(3):171–177, March 2022. URL: http://dx.doi.org/10.34172/aim.2022.29, doi:10.34172/aim.2022.29. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.34172/aim.2022.29)

[7. (Bos2007GEFs) Johannes L. Bos, Holger Rehmann, and Alfred Wittinghofer. Gefs and gaps: critical elements in the control of small g proteins. Cell, 129(5):865–877, June 2007. URL: http://dx.doi.org/10.1016/j.cell.2007.05.018, doi:10.1016/j.cell.2007.05.018. This article has 1450 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2007.05.018)

[8. (Xu2020MiR31213p) Ming Xu, Jun Zhou, Qiulei Zhang, Kehao Le, Zihan Xi, Pengfei Yi, Xiangwang Zhao, Jie Tan, and Tao Huang. Mir-3121-3p promotes tumor invasion and metastasis by suppressing rap1gap in papillary thyroid cancer in vitro. Annals of Translational Medicine, 8(19):1229–1229, October 2020. URL: http://dx.doi.org/10.21037/atm-20-4469, doi:10.21037/atm-20-4469. This article has 8 citations and is from a poor quality or predatory journal.](https://doi.org/10.21037/atm-20-4469)

[9. (Ding2018Methylation) Wen‑Jing Ding, Yi Yang, Zi‑Xing Chen, Yuan‑Yuan Wang, Wan‑Li Dong, Jian‑Nong Cen, Xiao‑Fei Qi, Feng Jiang, and Su‑Ning Chen. Methylation level of rap1gap and the clinical significance in mds. Oncology Letters, September 2018. URL: http://dx.doi.org/10.3892/ol.2018.9503, doi:10.3892/ol.2018.9503. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2018.9503)

[10. (Jiao2010Rap1GAP) Li Jiao, Yong Zhang, Chun Hu, Yong-Gang Wang, Aijun Huang, and Cheng He. Rap1gap interacts with ret and suppresses gdnf-induced neurite outgrowth. Cell Research, 21(2):327–337, September 2010. URL: http://dx.doi.org/10.1038/cr.2010.139, doi:10.1038/cr.2010.139. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2010.139)

[11. (Zhang2019Function) Lingmin Zhang, Manli Cui, Liping Song, Mingxin Zhang, and Jia Zhang. Function, significance, and regulation of rap1b in malignancy. Critical Reviews in Eukaryotic Gene Expression, 29(2):151–160, 2019. URL: http://dx.doi.org/10.1615/CRITREVEUKARYOTGENEEXPR.2019025997, doi:10.1615/critreveukaryotgeneexpr.2019025997. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1615/CRITREVEUKARYOTGENEEXPR.2019025997)

[12. (Rubinfeld1992Localization) Bonnee Rubinfeld, Walter J. Crosier, Iris Albert, Leah Conroy, Robin Clark, Frank Mccormick, and Paul Polakis. Localization of the raplgap catalytic domain and sites of phosphorylation by mutational analysis. Molecular and Cellular Biology, 12(10):4634–4642, October 1992. URL: http://dx.doi.org/10.1128/mcb.12.10.4634-4642.1992, doi:10.1128/mcb.12.10.4634-4642.1992. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.12.10.4634-4642.1992)

[13. (Jordan1999Modulation) J. Dedrick Jordan, Kendall D. Carey, Philip J.S. Stork, and Ravi Iyengar. Modulation of rap activity by direct interaction of gαo with rap1 gtpase-activating protein. Journal of Biological Chemistry, 274(31):21507–21510, July 1999. URL: http://dx.doi.org/10.1074/jbc.274.31.21507, doi:10.1074/jbc.274.31.21507. This article has 127 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.274.31.21507)

[14. (Jaśkiewicz2018The) Anna Jaśkiewicz, Beata Pająk, and Arkadiusz Orzechowski. The many faces of rap1 gtpase. International Journal of Molecular Sciences, 19(10):2848, September 2018. URL: http://dx.doi.org/10.3390/ijms19102848, doi:10.3390/ijms19102848. This article has 67 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms19102848)

[15. (Caron2003Cellular) Emmanuelle Caron. Cellular functions of the rap1 gtp-binding protein: a pattern emerges. Journal of Cell Science, 116(3):435–440, February 2003. URL: http://dx.doi.org/10.1242/jcs.00238, doi:10.1242/jcs.00238. This article has 183 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.00238)